KOTWAL GIRISH J has a total of 14 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are BACHMANN MARTIN F, SMITHKLINE BEECHAM BIOLOGICALS S.A. and EVOX THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Canada | 1 | |
#5 | United Kingdom | 1 | |
#6 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Kotwal Girish J | 14 |
#2 | Arason Guomundur Johann | 3 |
#3 | Ghebremarian Yohannes Tsegai | 1 |
#4 | Arason Gudmundur Johann | 1 |
#5 | Hicks Ramona | 1 |
#6 | Parhar Ranjit | 1 |
#7 | Jha Purushottam | 1 |
#8 | Al-Mohanna Futwan | 1 |
Publication | Filing date | Title |
---|---|---|
US2009054330A1 | Novel Therapeutic Use of Viral Inflammation Modulatory Protein in Blocking Xenograft Rejection | |
US2010172937A1 | Enveloped virus neutralizing compounds | |
US2008318858A1 | Isolated recombinant vaccinia virus complement control protein (hrVCP) polypeptide | |
EP2529746A1 | Methods for treatment or prophylaxis of reperfusion injury | |
US8080637B1 | Therapeutic method of treating brain trauma in rodents with VCP |